Enjaymo (sutimlimab-jome)

**Product type:** Human Prescription Drug

**Active ingredient:** SUTIMLIMAB

**Strength:** 50 mg/mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Recordati Rare Diseases, Inc.

**Marketing category:** BLA (BLA761164)

**Pharmacologic class:** Classical Complement Pathway Inhibitor [EPC], Classical Complement Pathway Inhibitors [MoA]